Semtech beats Q2 estimates but keeps cautious outlook
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Connected TV, retail media bolster Trade Desk’s solid quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Transphorm reports slightly higher revenue in first quarter
Goleta-based Transphorm reported its first-quarter earnings after the markets closed on Aug. 14, noting a slight raise in revenue. Transphorm, a supplier of gallium nitride power conversion products, generated $5.9 million in revenue in the first quarter up from $5.2 million in the same quarter a year ago. Moreover, the company’s net loss was $7.4 Read More →
Olaplex fails to meet expectations again, lowers guidance
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen gives confidence to investors on pending purchase
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind excites investors, analysts after huge bump in sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen delivers earnings beat despite acquisition headaches
Amgen delivered a sound beat of Wall Street analysts’ predictions for its second quarter of 2023 en route to posting a record revenue. The biotech giant reported a total revenue of just under $7 billion, beating the Yahoo Finance estimate by 4.6% and causing the stock to jump up 2.3% in after-hours trading. Amgen attributed Read More →
